Novartis’ targeted combination therapy recommended by NICE to treat childhood brain tumours
Gliomas are the most common type of brain cancer in paediatric patients
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Eisai and BioArctic sign research evaluation agreement for potential new Alzheimer’s treatment
AD is the most common form of dementia, which affects around 55 million people globally
Incyte announces agreement to acquire Escient Pharmaceuticals for $750m
The deal includes an MRGPRX2 antagonist with the potential to treat multiple mast cell-mediated diseases
Novartis’ targeted combination therapy recommended by NICE to treat childhood brain tumours
Gliomas are the most common type of brain cancer in paediatric patients
Sanofi announces UK launch of inactivated rabies vaccine Verorab for all age groups
The rare neurotrophic virus is responsible for an estimated 59,000 global deaths every year
PMLiVE’s T40 – open for submissions!
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
Latest content
Havas Life Medicom and Sciterion appoint Dick Dunford as group creative director
Dunford recently served as executive creative director at TBWA\WorldHealth
Read More
minds + assembly appoints Nick Colucci to board of directors
Colucci previously served as chief executive officer and chairman of Publicis Health
Read More
Intelligence
Rare diseases – raising awareness, listening to patients, making a difference
PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients with rare diseases and the barriers that are hindering access
Read More
Behavioural science – the route to healthcare salvation?
Industry is urged to ditch the simple slogans and instead embrace the complexity, as delving more deeply could improve success rates
Read More
Women’s health – managing the menopause
PME spoke to Marci English, Vice President and Head of BioPharma Development, Astellas, about the importance of new treatments for menopause symptoms, the unmet need and the company’s commitment to midlife women’s health
Read More
The killer question
Expert strategists ask four crucial questions – the first one confounds most of us
Read More
The battle against counterfeit drugs
PME spoke to Remi Turbet Delof from Systech about his work with customers to help them navigate the complex world of serialisation
Read More
The threat of AMR – when the drugs no longer work…
In the face of the increasing threat from AMR, the recent Bioinfect 2024 conference offers five reasons to be hopeful
Read More
Blogs
Latest
Showing Deep Expertise at ONS
April 24, 2024 | Medscape Education Global|CME, MedEd, Nursing, ONS2024, ONSCongress, medicaleducation, oncology
The Medscape Oncology team will be connecting with the oncology nursing community this week in Washington, DC for the ONS Congress 2024. Medscape Oncology has …
MEDSCAPE’S NEW AGE OF CERTAINTY FOR CME
April 24, 2024 | Medscape Education Global|Precision Education, impact, medical education, outcomes, transformation
The CME industry is changing. More than ever, activities need to be prioritized and measured to increase their impact on patient outcomes. Improving patient outcomes …
Rebrand for Cheshire creative agency, LOVELIVE
April 24, 2024 | LOVELIVE|
Cheshire creative agency LOVELIVE has unveiled a new-look branding; coinciding with the launch of a new website as they celebrate 22% year on year growth …
Fox&Cat Relaunches With An Industry-First Efficiency & Effectiveness Planning Framework, ADAPTTM
April 24, 2024 | Fox&Cat|Efficient and effective, High value, People-first, Senior consultant network, healthcare communications
F&C network team picture, March 2024 Fox&Cat relaunches today with its new people-first, senior consultant operating model and bespoke planning framework, ADAPTTM. The agency’s lean …
Research conducted for Johnson and Johnson published in scientific journal
April 17, 2024 | Research Partnership|
Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.
Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot
April 24, 2024 | Research Partnership|Syndicated, market research, oncology, therapy watch
This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a …
Navigating the future of AI: Insights from EphMRA’s one day meeting in London
April 22, 2024 | Research Partnership|
Authored by: Ellie Forde and Mark Braund, Directors
Navigating Stress: Understanding, Addressing, and Supporting Our Team
April 17, 2024 | Mednet Group|Stress Awareness Month
Explore how we’re supporting our team with managing stress in the workplace
Autoimmune conditions: Living With syndicated patient reports
April 11, 2024 | Research Partnership|
The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective …
What role does ICER play in US market access?
April 9, 2024 | Mtech Access|
The Institute for Clinical and Economic Review (ICER) is becoming an increasingly important player in US market access. As more transformative, but costly, treatments come …
Effective Communication in Virtual Meetings: Stay Pithy – Impetus InSite Tips #4
April 18, 2024 | Impetus Digital | Asynchronous touchpoints, DOL engagement, HCP engagement, KOL Engagement, MSL engagement, Pharma engagement, Virtual Pharma, Virtual advisory board, digital advisory board, pharma innovation, pharma virtual meeting